5591 results
Refine Your Search
Nicoletta Cieri
Nicoletta Cieri is a Postdoctoral Research Fellow at Cancer Institute. Before joining DFCI, Nicoletta obtained her MD degree summa cum laude and ment…
Novel CD7 CAR T-cells for refractory T-cell malignancies affecting pediatric and AYA patients
leukemias and lymphomas have devastating outcomes if they recur after or don’t respond to standard treatment, with the only hope of cure being bone ma…
Rayne Rouce
Dr. Rouce is a pediatric oncologist and physician scientist whose clinical research focuses on blood cancers, specifically how to harness the immune …
Enterome
Enterome is a biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.
A phase 2 trial of EO2463, a novel microbial-derived peptide therapeutic vaccine, as monotherapy, and in combination with lenalidomide and rituximab, for treatment of patients with indolent NHL
In October , LLS made an equity investment in Enterome to "support the ongoing Phase SIDNEY study of EO2463 in indolent lymphoma."Enterome is a bi…
Development of cellular therapy for CMML and the Immune landscape of response and resistance
We will test the efficacy of CAR T cell therapy for CMML. We will modify the tumor microenvironment to enhance their efficacy. and we will upscale CAR…
Huda Salman
My clinical and research interest is to develop therapies that enhance the immune system to fight blood cancer. I serve as the IND holder responsible …
Sam Butterworth
Sam Butterworth joined the University of Manchester as a Senior Lecturer in Medicinal Chemistry in November . Prior to this he worked at the Universit…
Development of peptide-drug conjugates for the treatment of Chronic Myelomonocytic Leukaemia (CMML)
We are aiming to bring a new treatment option to patients with chronic myelomonocytic leukemia (CMML) by utilising CCL2-drug conjugates that specifica…
CLL-1 CAR-T cells and trametinib for the treatment of Ras-mutated CMML and JMML
hypothesize that demonstrating activity of (CLL1CART) cell therapy with or without trametinib in models of chronic myelomonocytic leukemia (CMML) a…
Elliot Stieglitz
Dr. Elliot Stieglitz is a at the University of California, San Francisco whose research focuses on children diagnosed with juvenile myelomonocytic le…
Eric Padron
Eric Padron, MD is an Associate Member and Scientific Director of the Department of Hematology at Moffitt Cancer Center (MCC). He completed a hematolo…
Advancing the therapeutic landscape for Chronic Myelomonocytic Leukemia (CMML)
CMML is a universally lethal blood cancer characterized by increased monocytes (a type of white blood cell) in the peripheral blood and abnormal appea…
A phase 1 study of VIPER-101, a CD5-edited dual population chimeric antigen receptor cell therapy, to enhance immunotherapy against T-cell non-Hodgkin lymphoma
In October , LLS made an equity investment in Vittoria to "Support Clinical Development of , a Cell Therapy for lymphomas."Vittoria Biotherapeutics …
Vittoria Biotherapeutics
Vittoria Biotherapeutics is developing novel cell therapies that transcend the limitations of current cell therapies.
Our impact on blood cancer research
Research: Grants
Research: TAP
Targeting Leukemia Stem Cells with the Novel Antibody Drug Conjugate
To improve the cure rate of patients suffering from acute myeloid leukemia (AML), our study aims to target resistant leukemia stem cells by developing…
George Daley
George Q. Daley, MD, PhD is Dean, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at H…
Sheng Li
Dr. Sheng Li is an Associate Professor in the Department of Biochemistry and Molecular Medicine, with a secondary appointment in the Department of Tra…
Ivan Odak
My name is Ivan Odak and I am a postdoctoral researcher in the Brody lab. I am an accomplished researcher with authored papers, of which as first or…
Marina Konopleva
Dr. Konopleva is a Director of the Acute Leukemia Program and a of the Translational Blood Cancer Institute at Einstein/Montefiore Cancer Center, NY.…
Pooja Khandelwal
I am a pediatric oncologist and associate professor in the division of bone marrow transplantation at Cincinnati Children’s Hospital Medical Center. I…
Anouchka Laurent
My research interests are the identification of genetic alterations responsible for leukemia and lymphoma development and the elucidation of the mecha…